<VariationArchive RecordType="classified" VariationID="830694" VariationName="NC_000002.12:g.(?_202467509)_(202467699_?)del" VariationType="Deletion" Accession="VCV000830694" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2022-05-28" DateCreated="2020-04-15" MostRecentSubmission="2021-05-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819099" VariationID="830694">
      <GeneList>
        <Gene Symbol="BMPR2" FullName="bone morphogenetic protein receptor type 2" GeneID="659" HGNC_ID="HGNC:1078" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q33.1-33.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="202376327" stop="202567749" display_start="202376327" display_stop="202567749" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="203241049" stop="203432473" display_start="203241049" display_stop="203432473" Strand="+" />
          </Location>
          <OMIM>600799</OMIM>
          <Haploinsufficiency last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BMPR2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BMPR2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000002.12:g.(?_202467509)_(202467699_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q33.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="203332232" innerStop="203332422" display_start="203332232" display_stop="203332422" variantLength="191" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_203332232)_(203332422_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_203332232)_(203332422_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.12:g.(?_202467509)_(202467699_?)del AND Pulmonary hypertension, primary, 1" Accession="RCV001031309" Version="1">
        <ClassifiedConditionList TraitSetID="1804">
          <ClassifiedCondition DB="MedGen" ID="C4552070">Pulmonary hypertension, primary, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000002.12:g.(?_202467509)_(202467699_?)del AND Primary pulmonary hypertension" Accession="RCV001383551" Version="1">
        <ClassifiedConditionList TraitSetID="65277">
          <ClassifiedCondition DB="MedGen" ID="C0152171">Primary pulmonary hypertension</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-10-18" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2021-05-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16728714</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19555857</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21801371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28388887</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30578397</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1804" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3581" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pulmonary hypertension, primary, 1</ElementValue>
                <XRef ID="MONDO:0024533" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PAH</ElementValue>
                <XRef Type="MIM" ID="178600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PHT</ElementValue>
                <XRef Type="MIM" ID="178600" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PPH1</ElementValue>
                <XRef ID="GTR000553220" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="178600" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301658</ID>
                <ID Source="BookShelf">NBK1485</ID>
              </Citation>
              <XRef ID="422" DB="Orphanet" />
              <XRef ID="C4552070" DB="MedGen" />
              <XRef ID="MONDO:0024533" DB="MONDO" />
              <XRef Type="MIM" ID="178600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="65277" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55776" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Primary pulmonary hypertension</ElementValue>
                <XRef ID="HP:0002092" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0001999" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPH1</ElementValue>
              </Symbol>
              <XRef ID="C0152171" DB="MedGen" />
              <XRef ID="MONDO:0001999" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2355869" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6230686|MedGen:C0152171" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194615" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19555857</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21801371</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28388887</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16728714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30578397</ID>
          </Citation>
          <Comment>This variant is an in-frame deletion of the genomic region encompassing exon 3 of the BMPR2 gene. It preserves the integrity of the reading frame. This variant has been observed in individual(s) with pulmonary arterial hypertension (PMID: 28388887, 16728714, 21801371). This variant disrupts the p.Cys99 amino acid residue in BMPR2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19555857, 30578397, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BMPR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_203332232)_(203332422_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Idiopathic Pulmonary Hypertension</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0152171" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3108343" SubmissionDate="2021-01-07" DateLastUpdated="2021-05-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_001204.6_2_Deletion (exon 3)|MedGen:C0152171" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582717" DateUpdated="2021-05-10" DateCreated="2021-05-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28388887</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16728714</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21801371</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19555857</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30578397</ID>
          </Citation>
          <Comment>This variant is an in-frame deletion of the genomic region encompassing exon 3 of the BMPR2 gene. It preserves the integrity of the reading frame. This variant has been observed in individual(s) with pulmonary arterial hypertension (PMID: 28388887, 16728714, 21801371). This variant disrupts the p.Cys99 amino acid residue in BMPR2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19555857, 30578397, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BMPR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_203332232)_(203332422_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0152171" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2355869" TraitType="Disease" MappingType="Name" MappingValue="Idiopathic Pulmonary Hypertension" MappingRef="Preferred">
        <MedGen CUI="C4552070" Name="Pulmonary hypertension, primary, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3108343" TraitType="Disease" MappingType="XRef" MappingValue="C0152171" MappingRef="MedGen">
        <MedGen CUI="C0152171" Name="Primary pulmonary hypertension" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

